Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Drugs|January 9, 1998
Irbesartan. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertensionJ C Gillis, A MarkhamPharmacoeconomics|August 5, 1996
Streptokinase. A pharmacoeconomic appraisal of its use in the management of acute myocardial infarctionJ C Gillis, K L GoaDrugs|November 1, 1995
Tretinoin. A review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukaemiaJ C Gillis, K L GoaDrugs|March 1, 1995
Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteriaJ C Gillis, R N BrogdenDrugs|April 1, 1996
Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosisJ C Gillis, L R WisemanDrugs|January 1, 1997
Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain managementJ C Gillis, R N BrogdenDrugs & Aging|August 1, 1994
Idebenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in age-related cognitive disordersJ C Gillis, P Benefield, D McTavishDrugs|July 1, 1995
Transnasal butorphanol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute pain managementJ C Gillis, P Benfield, K L GoaDrugs|April 1, 1997
Octreotide long-acting release (LAR). A review of its pharmacological properties and therapeutic use in the management of acromegalyJ C Gillis, S Noble, K L GoaDrugs|November 14, 1997
Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsyH D Langtry, J C Gillis, R DavisPageof 2